Aziyo Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Aziyo Biologics's estimated annual revenue is currently $28.7M per year.
- Aziyo Biologics received $10.0M in venture funding in August 2018.
- Aziyo Biologics's estimated revenue per employee is $192,450
- Aziyo Biologics's total funding is $44.1M.
Employee Data
- Aziyo Biologics has 149 Employees.
- Aziyo Biologics grew their employee count by -10% last year.
Aziyo Biologics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP-Sales | Reveal Email/Phone |
2 | EVP and General Manager, Musculoskeletal Products | Reveal Email/Phone |
3 | VP Sales | Reveal Email/Phone |
4 | EVP, Operations & Product Development | Reveal Email/Phone |
5 | VP, Finance | Reveal Email/Phone |
6 | National Account Director | Reveal Email/Phone |
7 | Director, Quality and Regulatory Affairs | Reveal Email/Phone |
8 | Director Quality Assurance and Regulatory Affairs | Reveal Email/Phone |
9 | Marketing Director | Reveal Email/Phone |
10 | Senior Director Quality | Reveal Email/Phone |
Aziyo Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Aziyo Biologics?
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
keywords:N/A$44.1M
Total Funding
149
Number of Employees
$28.7M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aziyo Biologics News
SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and...
SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...
Maryland’s health tech startup ecosystem is at it again. Silver Spring-based Aziyo Biologics Inc. has raised $10 million from seven investors in a funding round disclosed Tuesday in SEC filings. Founded in 2015, Aziyo is a private, commercially-oriented biotech company focused on regenerative ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $54M | 152 | -7% | N/A |
#2 | $25M | 157 | -9% | N/A |
#3 | $39.7M | 159 | 18% | N/A |
#4 | $7.5M | 163 | 15% | N/A |
#5 | $33.3M | 168 | 17% | N/A |
Aziyo Biologics Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-08-08 | $10.0M | Undisclosed | Mulitple | Article |